Sildenafil and bosentan plasma concentrations in a human immunodeficiency virus-infected patient with pulmonary arterial hypertension treated with ritonavir-boosted protease inhibitor

• Asıl Yazarlar: Pierangelo Chinello (Yazar), Stefania Cicalini (Yazar), Simona Pichini (Yazar), Roberta Pacifici (Yazar), Massimo Tempestilli (Yazar), Maria P. Cicini (Yazar), Leopoldo P. Pucillo (Yazar), Nicola Petrosillo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2015-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Sildenafil and bosentan are increasingly used for the treatment of pulmonary arterial hypertension (PAH) in HIV-infected patients. However, concerns exist about pharmacokinetic interactions among sildenafil, bosentan and antiretroviral drugs, including protease inhibitors (PI). We describe here the...